Different effects of angiotensin converting enzyme inhibitors on endothelin-1 and nitric oxide balance in human vascular endothelial cells: Evidence of an oxidant-sensitive pathway

Mediators of Inflammation

Volumn 2008, Issue , 2008, Pages

  Desideri, Giovambattista ^a   Grassi, Davide ^a   Croce, Giuseppe ^a   Bocale, Raffaella ^a   Tiberti, Sergio ^a   Evangelista, Stefano ^b   Necozione, Stefano ^a   Di Orio, Ferdinando ^a   Ferri, Claudio ^a  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b Menarini Ricerche SpA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BRADYKININ B2 RECEPTOR; CAPTOPRIL; ENALAPRILAT; ENDOTHELIN 1; GLUTATHIONE; LISINOPRIL; NITRIC OXIDE; ZOFENOPRILAT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NITRATE; NITRITE; OXIDIZING AGENT;

ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN SECRETION; VASCULAR ENDOTHELIUM; CELL LINE; DRUG EFFECT; ENDOTHELIUM CELL; METABOLISM; OXIDATION REDUCTION REACTION; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CELL LINE; ENDOTHELIAL CELLS; ENDOTHELIN-1; GLUTATHIONE; HUMANS; NITRATES; NITRIC OXIDE; NITRITES; OXIDANTS; OXIDATION-REDUCTION; OXIDATIVE STRESS; SIGNAL TRANSDUCTION;

EID: 58149166857     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2008/305087     Document Type: Article

References (31)

1. Riordan J. F., Angiotensin-I-converting enzyme and its relatives Genome Biology 2003 4 8, article 225 1 5
2. Brown N. J., Vaughan D. E., Angiotensin-converting enzyme inhibitors Circulation 1998 97 14 1411 1420
3. Squire I. B., Angiotensin converting enzyme inhibition in heart failure: clinical trials and clinical practice Cardiovascular Drugs and Therapy 2002 16 1 67 74
4. Remuzzi G., Ruggenenti P., Perico N., Chronic renal diseases: renoprotective benefits of renin-angiotensin system inhibition Annals of Internal Medicine 2002 136 8 604 615
5. Bossaller C., Auch-Schwelk W., Weber F., Endothelium-dependent relaxations are augmented in rats chronically treated with the angiotensin-converting enzyme inhibitor enalapril Journal of Cardiovascular Pharmacology 1992 20 supplement 9 S91 S95
6. Takase H., Moreau P., Küng C. F., Nava E., Lüscher T. F., Antihypertensive therapy prevents endothelial dysfunction in chronic nitric oxide deficiency: effect of verapamil and trandolapril Hypertension 1996 27 1 25 31
7. Desideri G., Ferri C., Bellini C., De Mattia G., Santucci A., Effects of ACE inhibition on spontaneous and insulin-stimulated endothelin-1 secretion: in vitro and in vivo studies Diabetes 1997 46 1 81 86
8. Yanagisawa M., Kurihara H., Kimura S., A novel potent vasoconstrictor peptide produced by vascular endothelial cells Nature 1988 332 6163 411 415
9. Momose N., Fukuo K., Morimoto S., Ogihara T., Captopril inhibits endothelin-1 secretion from endothelial cells through bradykinin Hypertension 1993 21 6 921 924
10. Liu X., Engelman R. M., Rousou J. A., Cordis G. A., Das D. K., Attenuation of myocardial reperfusion injury by sulfhydryl-containing angiotensin converting enzyme inhibitors Cardiovascular Drugs and Therapy 1992 6 4 437 443
11. Mak I. T., Freedman A. M., Dickens B. F., Weglicki W. B., Protective effects of sulfhydryl-containing angiotensin converting enzyme inhibitors against free radical injury in endothelial cells Biochemical Pharmacology 1990 40 9 2169 2175
12. Pryor W. A., Squadrito G. L., The chemistry of peroxynitrite: a product from the reaction of nitric oxide with superoxide American Journal of Physiology 1995 268 5 L699 L722
13. Scribner A. W., Loscalzo J., Napoli C., The effect of angiotensin-converting enzyme inhibition on endothelial function and oxidant stress European Journal of Pharmacology 2003 482 1-3 95 99
14. Wu L., Juurlink B. H. J., The impaired glutathione system and its up-regulation by sulforaphane in vascular smooth muscle cells from spontaneously hypertensive rats Journal of Hypertension 2001 19 10 1819 1825
15. Desideri G., Bravi M. C., Tucci M., Angiotensin II inhibits endothelial cell motility through an AT1-dependent oxidant-sensitive decrement of nitric oxide availability Arteriosclerosis, Thrombosis, and Vascular Biology 2003 23 7 1218 1223
16. Ferri C., Pittoni V., Piccoli A., Insulin stimulates endothelin-1 secretion from human endothelial cells and modulates its circulating levels in vivo The Journal of Clinical Endocrinology and Metabolism 1995 80 3 829 835
17. Jaffe E. A., Nachman R. L., Becker C. G., Minick C. R., Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria The Journal of Clinical Investigation 1973 52 11 2745 2756
18. Evangelista S., Manzini S., Antioxidant and cardioprotective properties of the sulphydryl angiotensin-converting enzyme inhibitor zofenopril The Journal of International Medical Research 2005 33 1 42 54
19. Anderson M. E., Determination of glutathione and glutathione disulfide in biological samples Methods in Enzymology 1985 113 548 555
20. Thorburne S. K., Juurlink B. H. J., Low glutathione and high iron govern the susceptibility of oligodendroglial precursors to oxidative stress Journal of Neurochemistry 1996 67 3 1014 1022
21. Rossi G. P., Seccia T. M., Nussdorfer G. G., Reciprocal regulation of endothelin-1 and nitric oxide: relevance in the physiology and pathology of the cardiovascular system International Review of Cytology 2001 209 241 272
22. Haynes W. G., Webb D. J., Contribution of endogenous generation of endothelin-1 to basal vascular tone The Lancet 1994 344 8926 852 854
23. Pecháňová O., Šimko F., The role of nitric oxide in the maintenance of vasoactive balance Physiological Research 2007 56 supplement 2 S7 S16
24. Cominacini L., Pasini A. F., Garbin U., Zofenopril inhibits the expression of adhesion molecules on endothelial cells by reducing reactive oxygen species American Journal of Hypertension 2002 15 10 891 895
25. Napoli C., Sica V., de Nigris F., Sulfhydryl angiotensin-converting enzyme inhibition induces sustained reduction of systemic oxidative stress and improves the nitric oxide pathway in patients with essential hypertension American Heart Journal 2004 148 1 172
26. Pasini A. F., Garbin U., Nava M. C., Effect of sulfhydryl and non-sulfhydryl angiotensin-converting enzyme inhibitors on endothelial function in essential hypertensive patients American Journal of Hypertension 2007 20 4 443 450
27. Egan T. M., Minta J. O., Scrimgeour K. G., Cooper J. D., Captopril-a potential free radical scavenger: inhibition of PMN NADPH oxidase Clinical and Investigative Medicine 1988 11 5 351 356
28. Kukreja R. C., Kontos H. A., Hess M. L., Captopril and enalaprilat do not scavenge the superoxide anion The American Journal of Cardiology 1990 65 19 24 27
29. Soardo G., Donnini D., Moretti M., Milocco C., Catena C., Sechi L. A., Effects of antihypertensive drugs on alcohol-induced functional responses of cultured human endothelial cells Hypertension Research 2008 31 2 345 351
30. Dandona P., Ghanim H., Brooks D. P., Antioxidant activity of carvedilol in cardiovascular disease Journal of Hypertension 2007 25 4 731 741
31. Ambrosioni E., Borghi C., Magnani B., The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction The New England Journal of Medicine 1995 332 2 80 85